Ascendia Pharmaceutical Solutions is excited to announce our presence at this year’s INTERPHEX conference, taking place April 1–3 at the Javits Center in New York City. As the pharmaceutical industry continues to evolve with a focus on innovation, lifecycle management, and patient-centric drug delivery, Ascendia is proud to stand at the forefront — and this year, our own Dr. Shaukat Ali is helping lead the charge.
INTERPHEX 2025 marks a pivotal opportunity for scientists, engineers, and manufacturing leaders to connect with cutting-edge technologies and ideas shaping the future of pharmaceutical development. And no one embodies that spirit better than Dr. Ali.
Join Dr. Ali on April 1st for Two Scientific Sessions on Stage 2
Morning Panel (10:30–11:15 AM)
Topic: “Long-Acting Injectables and Implants: Reducing Dose Frequency”
Dr. Ali joins a panel of leading experts from across the pharmaceutical industry to explore the growing interest in long-acting drug delivery systems — from intramuscular and subcutaneous injections to innovative implants. As patients and providers seek to reduce pill burden while maintaining safety and efficacy, these delivery systems play an increasingly vital role in improving adherence and lifecycle management.
Afternoon Session (3:00–4:00 PM)
Topic: “Quick Fire Sessions – Stage 2 on Ensuring Access to Innovative Medicines”
Dr. Ali will moderate an engaging afternoon session featuring speakers from both academia and industry. With a focus on technological advancements, this session offers insights into how scientific expertise, advanced equipment, and process optimization are driving pharmaceutical manufacturing forward.
Why INTERPHEX Is Important to Ascendia and the Rest of the Industry
INTERPHEX has long been recognized as a premier venue for pharmaceutical equipment and manufacturing solutions. In recent years, the event has evolved further through a strategic alliance with AAPS (American Association of Pharmaceutical Scientists), bringing a deeper scientific focus to the conference. INTERPHEX is more than a trade show; it’s a learning experience, a chance to collaborate, innovate, and ultimately, solve unmet medical needs.
For Ascendia, this evolution aligns perfectly with our mission. As a rapidly growing CDMO with newly expanded capabilities — including state-of-the-art GMP facilities and microbial labs — Ascendia is actively investing in advanced equipment, green manufacturing practices, and sustainable innovation. INTERPHEX offers an unmatched opportunity to connect with leading equipment manufacturers, discover new technologies, and strengthen our role as scientific partners in solving some of pharma’s toughest formulation and delivery challenges.
Who Should Attend These Sessions?
Whether you’re working on lifecycle management strategies, trying to reduce dosing frequency, or exploring novel routes of administration for challenging compounds, you’ll find valuable insights and real-world applications in these sessions.
These panels are ideal for:
- Formulation scientists
- Process engineers
- Product development leaders
- Regulatory professionals
- Anyone interested in long-acting injectables or advanced manufacturing solutions
Let’s Meet at INTERPHEX
While Ascendia won’t have a booth at this year’s show, we’re making our presence felt through thought leadership and collaboration. Join us at Stage 2 on Monday, April 1st, for a dynamic exchange of ideas — and stay tuned as Ascendia continues expanding its role in shaping the future of drug delivery and development.
Want to connect with us at INTERPHEX? Reach out to schedule a meeting with Dr. Ali or a member of our team.